Cerebral glucose metabolism during pharmacologic studies: Test-retest under placebo conditions

Journal of Nuclear Medicine

Volumn 37, Issue 7, 1996, Pages 1142-1149

  Schmidt, Mark E ^a   Ernst, Monique ^b   Matochik, John A ^b   Maisog, Jose Ma ^b   Pan, Bai Shen ^b   Zametkin, Alan J ^b   Potter, William Z ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NONE

Author keywords

FDG PET; placebo; validation

Indexed keywords

DEXTROMETHORPHAN; FLUORODEOXYGLUCOSE; GLUCOSE; IDAZOXAN;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; FEMALE; GLUCOSE METABOLISM; HUMAN; ISOTOPE TRACING; MALE; MENTAL TASK; NORADRENALIN BLOOD LEVEL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; TASK PERFORMANCE;

ADULT; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CASE-CONTROL STUDIES; DEOXYGLUCOSE; DEXTROAMPHETAMINE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; NOREPINEPHRINE; PLACEBOS; REPRODUCIBILITY OF RESULTS; TASK PERFORMANCE AND ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029738515     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 18F] fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab 1992; 12:281-290.
2. Duara R, Gross-Glenn K, Barker WW, et al. Behavioral activation and the variability of cerebral glucose metabolic measurements. J Cereb Blood Flow Metab 1987;7:266-271.
3. Mazziota JC, Phelps ME, Carson RE, Kuhl DE. Tomographic mapping of human cerebral metabolism: sensory deprivation. Ann Neurol 1982;12:435-444.
4. Risberg J, Maximilian AV, Prohovnik I. Changes of cortical activity patterns during habituation to a reasoning test. Neuropsychologia 1977;15:793-798.
5. Gur RC, Gur RE, Resnick SM, Skolnick BE, Alavi A, Reivich M. The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab 1987;7:173-177.
6. Warach S, Gur RC, Gur RE, Skolnick BE, Obrist WD, Reivich M. Decreases in frontal and parietal lobe regional cerebral blood flow related to habitation. J Cereb Blood Flow Metab 1992;12:546-553.
7. Yoshii F, Barker WW, Chang JY, et al. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy and cerebrovascular risk factors. J Cereb Blood Flow Metab 1988;8:654-661.
8. Clark C, Carson R, Kessler R, et al. Alternative statistical models for the examination of clinical positron emission tomography/fluorodeoxyglucose data. J Cereb Blood Flow Metab 1985;5:142-150.
9. Fristen KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RSJ. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990;10:458-466.
10. Brooks RA, DiChiro G, Zukerberg BW, Bairamian D, Larson SM. Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: validation of method. J Nucl Med 1987;28:53-59.
11. Chang JY, Duara R, Barker W, Apicella A, Finn R. Two behavioral states studied in a single PET/FDG procedure: theory, method and preliminary results. J Nucl Med 1987;28:852-860.
12. Schmidt ME, Matochik JA, Risinger RC, et al. Regional glucose metabolism following acute alpha-2 blockade by idazoxan. Clin Pharm Therap 1995;57:684-695.
13. Ernst M, Zametkin AJ, Matochik JA, Liebenauer L, Fitzgerald GA, Cohen RM. Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD): preliminary findings. Psychopharmacol Bull 1994; 30:219-225.
14. Cohen RM, Semple WE, Gross M, Holcomb HH, Dowling MS, Nordahl TE. Functional localization of sustained attention: comparison to sensory stimulation in the absence of instruction. Neuropsych Neuropsychol Behav Neurol 1988;1:3-20.
15. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
16. Brooks RA. Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 1982;2:538-539.
17. 18F] 1-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388.
18. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82.
19. Matsui T, Hirano A. An atlas of the human brain for computerized tomography. New York: Igaku-Shoin Medical; 1978.
20. Bartko J. The intraclass correlation coefficient as a measure of reliability. Psych Rep 1966;19:3-11.
21. Mefford I, Caliguri EJ, Grady RK, Capella P, Durkin TA, Chevalier P. Microbore HPLC of biogenic amines in small biological samples. Meth Enzymol 1986;124:402-412.
22. Gur RE, Resnick SM, Gur RC, et al. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography. Arch Gen Psychiatry 1987;44:126-129.
23. 18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects. Eur J Nucl Med 1990;16:267-273.
24. Bartlett EJ, Brodie JD, Wolf AP, Christman DR, Laska E, Meissner M. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood How Metab 1988;8:502-512.
25. Tyler JL, Strother SC, Zatorre RJ, et al. Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography. J Nucl Med 1988;29:631-642.
26. 11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects. J Cereb Blood Flow Metab 1982;2:307-319.
27. Kuwabara H, Gjedde A. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate. J Nucl Med 1991;32:692-698.
28. Chang JY, Duara R, Barker W, et al. Two behavioral states studied in a single PET/FDG procedure: error analysis. J Nucl Med 1989;30:93-105.
29. Eastman RC, Carson RE, Gordon MR, et al. Brain glucose metabolism in noninsulin dependent diabetes mellitus: a study in Pima Indians using positron emission tomography during hyperinsulinemia with euglycemic glucose clamp. J Clin Endocrinol Metab 1990;71:1602-1610.
30. Giordani B, Boivin MJ, Berent S, et al. Anxiety and cerebral cortical metabolism in normal persons. Psychiatry Res Neuroimaging 1990;35:49-60.
31. Reivich M, Alavi A, Gur RC. Positron emission tomographic studies of perceptual tasks. Ann Neurol 1984;15(suppl):S61-S65.
32. Cameron OG, Modell JG, Hichwa RD, Agranoff BW, Koeppe RA. Changes in sensory-cognitive input: effects on cerebral blood flow. J Cereb Blood Flow Metab 1990;10:38-42.
33. Room P, Tielemans AJPC. Circadian variations in local cerebral glucose utilization in freely moving rats. Brain Res 1989;505:321-325.
34. 18F]2-fluoro-2-deoxy-D-glucose method. Brain Res 1990;513:136-143.
35. Buchsbaum MS, Gillin JC, Wu J, et al. Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci 1989;45:1349-1356.
36. Volkow ND, Wang GJ, Hitzemann, et al. Depression of thalamic metabolism by lorazepam is associated with sleepiness. Neuropsychopharmacology 1995;12:123-132.
37. Friston KJ, Grasby PM, Bench CJ, et al. Measuring the neuromodulalory effects of drugs in man with positron emission tomography. Neurosci Lett 1992;141:106-110.